| Literature DB >> 31803685 |
Sohini Das1, Manoj Job1, Thomas Kodiatte2, Ramya Iyadurai1.
Abstract
Intrahepatic cholangiocarcinoma is an uncommon malignancy which usually occurs in the 7th decade. Here we present a postpartum patient with fever, hepatomegaly, and ascites, who was diagnosed to have metastatic intrahepatic cholangiocarcinoma. Copyright:Entities:
Keywords: Cholangiocarcinoma; jaundice in pregnancy; pregnancy associated cancer
Year: 2019 PMID: 31803685 PMCID: PMC6881913 DOI: 10.4103/jfmpc.jfmpc_748_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Relevant laboratory investigations
| Test | Patient’s Values | Reference Range |
|---|---|---|
| Hemoglobin (gram/dl) | 8.5 | 11-15 |
| Total Leucocyte Count (mm3) | 13,400 | 4,400-11,000/µL |
| Neutrophils | 84 | 40-70% |
| Lymphocytes | 8 | 20-40% |
| Monocytes | 8 | 2-6% |
| Platelets | 3,42,000 | 1.5-4.5 lacs/µL |
| Creatinine (mg/dL) | 0.52 | 0.5-1.4 |
| Total bilirubin (mg/dl) | 0.50 | 0.5-1 |
| Direct bilirubin | 0.35 | 0.5-1 |
| SGOT (U/L) | 48 | 8-40 |
| SGPT (U/L) | 31 | 5-35 |
| Alkaline phosphatase (U/L) | 302 | 40-125 |
| Total protein (gram/dl) | 5.9 | 6-8.5 |
| Albumin (gram/dl) | 2.1 | 3.5-5 |
| Gamma-glutamyl transferase (U/L) | 106 | <55 |
| Beta-HCG (mIU/ml) | 11 | <5 |
| Carcinoembryonic Antigen | 11.5 | <5 |
| Alpha-fetoprotein (IU/ml) | 29.6 | <5 |
| HIV 1 and 2 antibodies | Non-reactive | |
| Hepatitis B surface antigen | Negative | |
| Hepatitis C antibody | Negative |
Figure 1Photomicrograph depicting infiltrating malignant tumor glands (black arrow) of cholangiocarcinoma (400×, H and E)
Cholangiocarcinoma diagnosed in pregnancy/postpartum period
| Clinical Features | Case 1 (Qasrawi | Case 2 (Balderston | Case 3 (Goswami |
|---|---|---|---|
| Age | 38 | 23 | 22 |
| Obstetric history | 4th pregnancy | Primigravida | NA |
| Symptoms and duration | RUQ pain, dark urine - one week | Vomiting, abdominal pain& | Abdominal pain, weight loss, fever-three weeks |
| Gestation in weeks at symptom onset | 36 | 26 | 2 weeks post-partum |
| Abnormal examination findings | Palpable liver, jaundice | RUQ mass, jaundice, new onset high blood pressure | RUQ mass, jaundice |
| Onset of jaundice | 36 weeks of gestation | 26 weeks of gestation | 2 weeks postpartum |
| Laboratory investigations (Reference range): | |||
| Total bilirubin in mg/dL (0.5-1) | 6.4 | 3.6→5.1 | 17.3 |
| Direct bilirubin in mg/dL | 5 | NA | 10.5 |
| Aspartate Aminotransferase in Units/L (8-40) | 83 | 70 | 95 |
| Alanine Aminotransferase in Units/L (5-35) | 87 | 31 | 70 |
| Alkaline Phosphatase in Units/L (40-125) | 319 | NA | 680 |
| Prothrombin Time with International Normalized ratio in seconds (11-13.5) | 17 and 1.4 | NA and 1.8 | NA |
| Imaging: | |||
| Ultrasound | Hepatomegaly with liver mass | Liver mass lesion | Dilated CBD with filling defect |
| Computed Tomography | NA | NA | Intramural lesions in CBD, cystic duct, gall bladder; dilated gallbladder and CBD |
| Magnetic Resonance Imaging | Mass lesions in the liver; intrahepatic biliary dilation | NA | NA |
| Endoscopic Retrograde Cholangio-Pancreatography | Not done | Right sided hepatic tumor; constriction of right biliary system and CBD | Dilated CBD with obstruction |
| Final Diagnosis | Intrahepatic cholangiocarcinoma | Intrahepatic cholangiocarcinoma | Biliary intraductal neoplasm |
| Outcome | Died 6 months after diagnosis | Died 3 weeks after diagnosis | NA |
&Symptom duration not available; NA-Details not available; CBD-Common Bile Duct; RUQ-right upper quadrant